WMHCA: Psychedelic Harm Reduction & Integration (PHRI) Psychotherapy: Best Practices & Current Trends
Presented by
Dr. Peter H. Addy, PhD, LPC, LMHCThis 3-hour training equips Washington mental health professionals with evidence- based knowledge and practical skills for Psychedelic Harm Reduction and Integration (PHRI) psychotherapy.
Overview
Recorded: February, 2026 3 CEs
This 3-hour training equips Washington mental health professionals with evidence- based knowledge and practical skills for Psychedelic Harm Reduction and Integration (PHRI) psychotherapy. This emerging therapeutic approach supports clients navigating psychedelic use in an evolving legal landscape. Washington clinicians increasingly encounter clients who use or are considering psychedelics.
This training does NOT provide instruction in directly administering psychedelics or endorse illegal activities. It operates strictly within the harm reduction and integration framework that defines PHRI psychotherapy and falls within Washington mental health professionals ; scope of practice. The focus is on supporting client safety, informed decision-making, and therapeutic processing of psychedelic experiences—skills that are immediately applicable to clinical practice.
Participants will leave with practical assessment tools, documentation strategies, harm reduction resources to share with clients, and integration techniques that can be implemented immediately in PHRI psychotherapy practice.
Objectives
- Distinguish between four levels of professional engagement to determine appropriate scope of practice and professional boundaries when working with clients who use or are considering psychedelic substances.
- Apply evidence-based screening protocols to assess client suitability for psychedelic use.
- Implement three evidence-based integration techniques to help clients process insights and experiences from psychedelic use.
About the Presenter
Dr. Peter Addy, LMHC, is an expert in the field of psychedelic substances and states of consciousness. With 15 years of experience, Dr. Addy has established himself as an authority on the transformative effects of transcendence and wholeness. Dr. Addy received his Ph.D. in clinical psychology, where he conducted one of the earliest studies on the atypical psychedelic plant Salvia divinorum in humans. He continued his research at Yale University, where he co-founded the Yale Psychedelic Science Group and studied other atypical psychedelics. Dr. Addy's expertise extends to substance use disorder treatment, having completed postdoctoral training in the field. In addition to his academic credentials, Dr. Addy has also traveled to Mexico to learn about the indigenous use of psychedelic plants and participated in non-directive harm reduction and integration training at Burning Man. Dr. Addy's knowledge and expertise have led him to become a highly sought-after speaker and presenter, having given talks internationally on a range of topics related to spirituality, trans-personal states,psychedelic science, and research methodology. Dr. Addy is also an accomplished writer, having authored numerous scientific articles, book chapters, and popular press articles on typical and atypical psychedelics, substance abuse, and spirituality. He currently practices as a psychotherapist in private practice in both Washington and Oregon, where he continues to apply his knowledge and expertise to help others achieve transformative experiences.